Potassium permanganate toxicity: A rare case with difficult airway management and hepatic damage
Sir, We read case report "potassium permanganate (KMnO 4 ) toxicity: A rare case with difficult airway management and hepatic damage" by Agrawal et al. [1] with great interest. We would like to discuss some points regarding the management of the patient.
Potassium permanganate is a powerful oxidizing agent. Free radicals generated due to absorbed permanganate ion overwhelm reduced tissue glutathione stores and causes liver injury. Its clinical course closely resembles that of paracetamol poisoning. [2] Hepatic injury due to a similar mechanism is also seen in toxicities due to carbon tetrachloride, chloroform, clove oil and amanita mushroom.
N-acetylcysteine (NAC) acts as an antioxidant, both directly as a glutathione substitute and indirectly as a precursor for glutathione. It also causes vasodilatation by increasing cyclic guanosine monophosphate level, inhibits platelet aggregation, acts as a sulfydryl donor to regenerate endothelial derived relaxing factor and reduce interleukin-8 and tumor necrosis factor-alpha production. [3] It improves transplant free survival in early stage nonacetaminophen acute liver failure [4] and also of great benefit in centers without facility for liver transplantation. [5] Use of NAC has shown good outcome in above mentioned toxicities, which are oxidizing agents like KMnO 4 .
Hence, we suggest an early use of NAC in KMnO 4 poisoning to prevent or reduce hepatic injury as also suggested by Young et al. [2] 
